Physician profile
Kenneth Chadwic Adkins
NPI 1629176540
$16,579.91
in general payments reported to CMS, 2019-2025
57 companies · $2,090 in 2025
The $2,090 reported for 2025 was more than what 96% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,413 · 2020: $1,843 · 2021: $1,968 · 2022: $2,473 · 2023: $2,830 · 2024: $2,965 · 2025: $2,090.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,867 · Education: $17.38.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,866.61 |
| Education | $17.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $2,552.79 | 2019-2025 | Breztri, Fasenra, Farxiga |
| Pfizer INC. | $1,941.40 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $1,213.25 | 2019-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,157.70 | 2019-2025 | Jardiance, Ofev |
| Novartis Pharmaceuticals Corporation | $957.02 | 2019-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $697.98 | 2019-2025 | Xifaxan |
| Bayer Healthcare Pharmaceuticals INC. | $605.72 | 2021-2025 | |
| Novo Nordisk INC | $587.86 | 2019-2025 | Wegovy, Ozempic |
| Abbott Laboratories | $540.49 | 2021-2025 | Freestyle Libre 2 |
| Abbvie INC. | $533.41 | 2021-2025 | Vraylar, Viberzi, Linzess |
| Glaxosmithkline, LLC. | $509.02 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Amgen INC. | $495.36 | 2019-2024 | Tezspire |
| Lilly USA, LLC | $407.65 | 2019-2025 | Jardiance, Mounjaro, Zepbound |
| Mylan Specialty L.P. | $360.50 | 2019-2024 | Yupelri |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $321.10 | 2019-2025 | Lifevest |
Show all 57 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sunovion Pharmaceuticals INC. | $318.10 | 2019-2020 | |
| Esperion Therapeutics, INC. | $312.91 | 2020-2025 | Nexletol |
| Amarin Pharma, INC. | $292.55 | 2019-2023 | |
| Exact Sciences Corporation | $269.02 | 2023-2025 | Cologuard Collection Kit |
| Allergan, INC. | $248.10 | 2019-2020 | |
| Verona Pharma, INC. | $220.51 | 2025 | Ohtuvayre |
| Lexicon Pharmaceuticals, INC. | $156.36 | 2023-2024 | Inpefa |
| Insmed, INC. | $154.38 | 2025 | Arikayce, Brinsupri |
| Lundbeck LLC | $115.69 | 2022-2025 | Vyepti |
| Eisai INC. | $109.85 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $109.66 | 2023-2025 | Verquvo, Belsomra, Gardasil 9 |
| Tactile Systems Technology INC | $97.45 | 2022-2024 | Flexitouch Plus, Entre Plus |
| Shield Therapeutics INC | $96.24 | 2024 | |
| Neurocrine Biosciences, INC. | $95.33 | 2024 | Ingrezza |
| Axsome Therapeutics, INC. | $90.55 | 2022-2025 | Sunosi |
| Regeneron Healthcare Solutions, INC. | $88.37 | 2024-2025 | Dupixent |
| Averitas Pharma INC. | $84.53 | 2023-2024 | Qutenza |
| E.R. Squibb & Sons, L.L.C. | $73.86 | 2022-2023 | Eliquis |
| Paratek Pharmaceuticals, INC. | $71.29 | 2022-2023 | Nuzyra |
| Takeda Pharmaceuticals U.S.A., INC. | $67.45 | 2021-2022 | |
| Baxter Healthcare | $67.28 | 2022-2025 | Hillrom - Vest System Model 105 Home Care |
| Dexcom, INC. | $62.58 | 2021-2024 | Dexcom G6 Transmitter |
| Daiichi Sankyo INC. | $60.79 | 2021-2022 | |
| Scpharmaceuticals INC. | $51.24 | 2024 | |
| Biohaven Pharmaceutical Holding Company LTD. | $42.50 | 2022 | |
| Astellas Pharma US INC | $33.85 | 2023-2024 | Myrbetriq, Veozah |
| Medtronic, INC. | $29.06 | 2022 | |
| Almatica Pharma LLC | $28.54 | 2021 | |
| Sanofi-Aventis U.S. LLC | $24.05 | 2020 | |
| Scilex Pharmaceuticals INC. | $23.98 | 2019 | |
| Genzyme Corporation | $23.40 | 2024 | |
| Apria Healthcare LLC | $23.36 | 2021 | |
| Optinose US, INC. | $21.35 | 2020 | |
| Assertio Therapeutics, INC. | $20.01 | 2019 | |
| Pulmonx Corporation | $19.42 | 2022 | |
| Harmony Biosciences LLC | $18.35 | 2025 | |
| Heartflow, INC. | $15.23 | 2024 | |
| Kowa Pharmaceuticals America, INC. | $14.65 | 2019 | |
| Phathom Pharmaceuticals, INC. | $13.17 | 2024 | Voquezna |
| Biogen, INC. | $12.09 | 2021 | |
| Jazz Pharmaceuticals INC. | $11.84 | 2022 | |
| Ambu INC. | $9.72 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Adkins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.